FAKTOR OPTIONSSCHEIN - BECTON DICKINSON AND CO. Stock

Certificat

DE000GK94PF1

Real-time BOERSE MUENCHEN 02:26:11 2024-07-12 pm EDT
5.717 EUR +2.86% Intraday chart for FAKTOR OPTIONSSCHEIN - BECTON DICKINSON AND CO.
Current month-8.21%
1 month-11.11%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 5.717 +2.86%
24-07-11 5.558 +1.94%
24-07-10 5.452 +0.91%
24-07-09 5.403 -3.88%
24-07-08 5.621 -1.20%

Real-time BOERSE MUENCHEN

Last update July 12, 2024 at 02:26 pm EDT

More quotes

Static data

Product typeWarrant Esotici e Strutturati
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Goldman Sachs
WKN GK94PF
ISINDE000GK94PF1
Date issued 2022-08-15
Strike 112.5 $
Maturity Unlimited
Parity 18.74 : 1
Emission price 10.03
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.5
Lowest since issue 5.383
Spread 0.01
Spread %0.17%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
224.9 USD
Average target price
277.8 USD
Spread / Average Target
+23.50%
Consensus